Sidi Mohamed El Amine Benlazar: How Romiplostim Induces Immune Tolerance in the Treatment of ITP
Sidi Mohamed El Amine Benlazar, Professor of Hematology, Head of the Hospitalization and Geriatric Unit at the University Hospital of Sidi Bel Abbès, shared a post on X about a recent article by Vivianne S. Nelson et al., published in British Journal of Haematology, adding:
“How romiplostim Induces Immune Tolerance in the Treatment of ITP.
Increased anergic B cells and decreased antibody-secreting cells during romiplostim treatment in patients with immune thrombocytopenia.”
Title: Increased anergic B cells and decreased antibody-secreting cells during romiplostim treatment in patients with immune thrombocytopenia
Authors: Vivianne S. Nelson, Rebeca Gutiérrez-Cózar, Rebecca Cornelis, S. Marieke van Ham, Anja ten Brinke, and Rick Kapur
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 10, 2026, 15:14Cihan Ay: PhD With Distinction in Thrombosis Research in Patients With Primary Brain Tumors
-
Oct 10, 2026, 15:07Khalid Ahmed: Mortality and Survival in Young People With Sickle Cell Disease and Beta Thalassaemia in England 1997 to 2025
-
Oct 10, 2026, 14:59Matteo Foschi: Antithrombotic Therapy in Secondary Stroke Prevention 10 Clinical Pearls Every Clinician Should Know
-
Oct 10, 2026, 14:33Ahmad Gharehbaghian: Supporting Blood Transfusion Teams and Strengthening Iran’s Blood Supply
-
Oct 10, 2026, 14:17Caitlin Raymond: Long-Term Infection Risk With ECP in GVHD
-
Oct 10, 2026, 14:09Emmanuel J Favaloro: 100 years of von Willebrand Disease in 2026
-
Oct 10, 2026, 13:54WFH Strengthens Collaboration to Advance Hemophilia Care in Paraguay
-
Oct 10, 2026, 13:40Shayan Mohammadmoradi: Platelets as Stress Sensors A New Perspective on Platelet Biology
-
Oct 10, 2026, 13:32Edward Lee Carter: When Normal Ferritin Does Not Rule Out Iron Deficiency